Literature DB >> 3778275

Metastasis from untreated uveal melanomas.

J M Pach, D M Robertson.   

Abstract

From 1969 to 1985, 224 cases of choroidal or ciliary body malignant melanoma had metastatic evaluations at the Mayo Clinic, Rochester, Minn. Five cases (2.2%) were found to have evidence of metastasis during the pretreatment evaluation. In each case, metastatic melanoma was verified histologically. Prior to enucleation or radiation treatment, we recommend a general medical evaluation, liver enzyme studies, and chest roentgenogram. Computed tomography (CT) of the liver should be performed if liver involvement is suggested by either the general medical evaluation or liver enzyme studies. Although CT of the liver in the initial surveillance of patients with choroidal or ciliary body melanoma is routinely performed at our institution, CT is not likely to produce a high yield of detectable disease in the presence of normal liver enzyme levels.

Entities:  

Mesh:

Year:  1986        PMID: 3778275     DOI: 10.1001/archopht.1986.01050230062032

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

Review 1.  The Zimmerman-McLean-Foster hypothesis: 25 years later.

Authors:  A D Singh; I G Rennie; T Kivela; S Seregard; H Grossniklaus
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

2.  Modelling uveal melanoma.

Authors:  A J Foss; I A Cree; P J Dolin; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

3.  Whole body PET/CT for initial staging of choroidal melanoma.

Authors:  P T Finger; M Kurli; S Reddy; L B Tena; A C Pavlick
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

4.  "Melanoma inhibitory activity" (MIA): a promising serological tumour marker in metastatic uveal melanoma.

Authors:  I W Reiniger; U C Schaller; C Haritoglou; R Hein; A K Bosserhoff; A Kampik; A J Mueller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-05-20       Impact factor: 3.117

5.  Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction.

Authors:  Paul R van Ginkel; Soesiawati R Darjatmoko; Dhruv Sareen; Lalita Subramanian; Saswati Bhattacharya; Mary J Lindstrom; Daniel M Albert; Arthur S Polans
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

Review 6.  Is observation really appropriate for small choroidal melanomas.

Authors:  J J Augsburger
Journal:  Trans Am Ophthalmol Soc       Date:  1993

Review 7.  Genetic determinants of uveal melanoma.

Authors:  Jasbir Kaur; Manzoor Ahmad Malik; Rishabh Gulati; Shorya Vardhan Azad; Sandeep Goswami
Journal:  Tumour Biol       Date:  2014-10-09

8.  Metastasis rates and sites after treatment for choroidal melanoma by proton beam irradiation or by enucleation.

Authors:  Chryssanthi Koutsandrea; Marilita M Moschos; Michael Dimissianos; Gerasimos Georgopoulos; Ioannnis Ladas; Michael Apostolopoulos
Journal:  Clin Ophthalmol       Date:  2008-12

Review 9.  Proteomics of uveal melanoma: a minireview.

Authors:  Søren K O Abildgaard; Henrik Vorum
Journal:  J Oncol       Date:  2013-09-03       Impact factor: 4.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.